In Vivo Efficacy Evaluation of Vaccines Against H5N1 Influenza Virus

被引：0
|
作者：
Mytle, Nutan [1 ]
机构：
[1] So Res Inst, Birmingham, AL 35255 USA
来源：
ANTIVIRAL RESEARCH | 2009年 / 82卷 / 02期
关键词：
D O I：
10.1016/j.antiviral.2009.02.177
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
175
引用
收藏
页码：A71 / A71
页数：1
相关论文
共 50 条
  • [31] Development of DNA Vaccine against Avian Influenza A Virus (H5N1)
    Ahmed, Shaheen
    Bronich, Tatiana K.
    Kabanov, Alexander V.
    [J]. MOLECULAR THERAPY, 2011, 19 (07) : 1392 - 1393
  • [32] Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus
    Khurana, Surender
    King, Lisa R.
    Manischewitz, Jody
    Posadas, Olivia
    Mishra, Ashish K.
    Liu, Dongxiao
    Beigel, John H.
    Rappuoli, Rino
    Tsang, John S.
    Golding, Hana
    [J]. NATURE MEDICINE, 2024,
  • [33] Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs
    Vincent, Amy L.
    Ciacci-Zanella, Janice R.
    Lorusso, Alessio
    Gauger, Philip C.
    Zanella, Eraldo L.
    Kehrli, Marcus E., Jr.
    Janke, Bruce H.
    Lager, Kelly M.
    [J]. VACCINE, 2010, 28 (15) : 2782 - 2787
  • [34] Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques
    Stittelaar, K. J.
    Tisdale, M.
    van Amerongen, G.
    van Lavieren, R. F.
    Pistoor, E.
    Simon, J.
    Osterhaus, A. D. M. E.
    [J]. ANTIVIRAL RESEARCH, 2008, 80 (02) : 225 - 228
  • [35] Long-term efficacy of an inactivated whole particle H5N1 virus against H5N1 highly pathogenic avian influenza virus challenge in cynomolgus monkeys
    Nakayama, M.
    Ishigaki, H.
    Cong, N. Thanh
    Suzuki, S.
    Ishida, H.
    Kitagawa, N.
    Ogasawara, K.
    Itoh, Y.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [36] In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide
    Duan, Ming
    Zhou, Zhe
    Lin, Ru-Xian
    Yang, Jing
    Xia, Xian-Zhu
    Wang, Sheng-Qi
    [J]. ANTIVIRAL THERAPY, 2008, 13 (01) : 109 - 114
  • [37] MAbs to avian influenza H5N1 virus
    Yang, M.
    Clavijo, A.
    [J]. HYBRIDOMA, 2007, 26 (03): : 182 - 183
  • [38] Influenza virus A (H5N1) risk factors
    不详
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (05): : 371 - 371
  • [39] Avian Influenza A(H5N1) Virus in Egypt
    Kayali, Ghazi
    Kandeil, Ahmed
    EI-Shesheny, Rabeh
    Kayed, Ahmed S.
    Maatouq, Asmaa M.
    Cai, Zhipeng
    McKenzie, Pamela P.
    Webby, Richard J.
    El Refaey, Samir
    Kandeel, Amr
    Ali, Mohamed A.
    [J]. EMERGING INFECTIOUS DISEASES, 2016, 22 (03) : 379 - 388
  • [40] Influenza type A (H5N1) virus infection
    Engin, Aynur
    [J]. MIKROBIYOLOJI BULTENI, 2007, 41 (03): : 485 - 494
12345